FOXP3 and diabetes mellitus: These results suggest that the liposomal α-GalCer treatment with insulin B 9–23 peptide might enhance the peptide-dependent accumulation of Foxp3+ Tregs in islets, followed by the preventive effect against the spontaneous development of diabetes and protective activity against insulitis progression in NOD mice.